secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001104659-25-015658
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences prices $6M public offering of 2.6M units at $2.33/unit
---------------------------------------------------------------------------

- Gross proceeds ~$6M from offering of 2,575,107 units at $2.33/unit; closed Feb 18, 2025.
- Each unit consists of one common share (or pre-funded warrant) and one warrant to buy one share at $5.83, subject to stockholder approval.
- Warrants have reset mechanism (floor $1.25) and alternative cashless exercise (1.2x shares); expire after merger or 60 days post approval.
- Net proceeds for general corporate purposes, merger with Vyome, asset sale to Ninjour; up to 50% to prepay Ascent Partners note.
- Maxim Group LLC acted as sole placement agent with 7% cash fee and 128,755 placement agent warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925015658/0001104659-25-015658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925015658/tm253570d16_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-015658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer